Skip to main content
Powerfabric

Standard

GAMP 5 (Pharma Automation Validation)

Good Automated Manufacturing Practice — risk-based validation framework for computerized systems in regulated pharma and life-science manufacturing.

Clean flowchart showing GAMP 5 pharma automation validation clause structure, verification workflow, and certification path.

Scope

Validation of computerized systems in regulated GxP environments

GAMP 5 (Pharma Automation Validation): Practical Guide for Engineers and Auditors

GAMP 5, published by ISPE, is the most widely used practical framework for validating automated systems in regulated life sciences environments. It is not a law or an IEC standard; rather, it is a risk-based methodology that helps demonstrate fitness for intended use for systems that affect product quality, patient safety, and data integrity. In practice, it shapes how engineers design, document, test, and maintain automation systems for pharmaceuticals, biotech, and adjacent regulated industries.

For automation engineers, panel builders, SCADA architects, and EPC contractors, the value of GAMP 5 is simple: it tells you how much evidence is enough, where to focus effort, and how to avoid over-validating low-risk functions while under-validating critical ones.

1) Scope and exclusions

GAMP 5 applies to computerized systems used in regulated GxP activities, especially those supporting manufacturing, laboratory operations, packaging, utilities, and electronic records/signatures. Its focus is on lifecycle validation and control of risk, not on product design rules for machines or electrical installations.

Typical in-scope systems include:

  • PLC-based batch control systems
  • SCADA and historian platforms
  • MES, LIMS, and ERP interfaces where GxP data is created or used
  • Electronic batch record systems
  • Alarm and event management systems
  • Data acquisition systems for critical utilities, cleanrooms, and process equipment

Typical exclusions or adjacent domains include:

  • Purely non-GxP business IT systems, unless they feed regulated records
  • General machine safety design, which is governed by standards such as ISO 12100, IEC 60204-1, and IEC 62061 or ISO 13849-1
  • Electrical installation compliance, governed by IEC 60364, EN 60204-1, NFPA 70, and relevant national wiring rules
  • Intrinsic cybersecurity frameworks outside the data-integrity context, though GAMP 5 strongly expects risk-based controls aligned with good security practice

Important practical point: GAMP 5 does not replace CE marking, machinery safety, or electrical conformity assessment. A pharma filling line may need both GAMP validation and CE technical documentation. These are different compliance objectives.

2) Structure of the document

GAMP 5 is organized around a lifecycle and a risk-based “fit for intended use” approach. The structure is designed to move from business need to verified operation, with controlled change throughout the system life.

Core structure engineers should understand

  • Concept and business process understanding
  • Category-based supplier and system approach
  • Quality risk management
  • Specification and design control
  • Configuration, build, and testing
  • Release, operation, and change management
  • Periodic review, incident handling, and retirement

The practical message is that validation is not a single test event. It is a controlled lifecycle, and the evidence package should trace from user needs to design, testing, release, and ongoing state of control.

3) The most important clauses and concepts engineers actually use

Because GAMP 5 is guidance rather than a clause-numbered normative standard, engineers usually reference its core principles rather than specific mandatory clauses. The following concepts are the ones auditors and validation leads ask about most often.

Clause / concept Purpose Why it matters in practice
Risk-based approach Focus validation effort on patient/product/data risk Prevents excessive testing of low-impact functions and ensures critical functions are robustly controlled
Defined intended use Establish what the system must do in the regulated process Without a clear intended use, requirements, test scope, and acceptance criteria become weak
User Requirements Specification (URS) Capture business, operational, quality, and compliance needs The URS is the anchor for traceability and later testing
Supplier assessment Determine reliance on vendor quality and product maturity Commercial off-the-shelf systems may justify reduced bespoke testing if supplier evidence is strong
Configuration over custom code Prefer standard functionality and controlled configuration Reduces defect risk and validation burden
Traceability Link requirements, design, tests, and deviations Auditors look for complete coverage and justified gaps
Data integrity and audit trail Ensure records are complete, accurate, attributable, and secure Critical for ALCOA+ expectations and inspection readiness
Change control and periodic review Maintain validated state after go-live Most validation failures occur after release, not during initial testing

In parallel, auditors often expect lifecycle evidence aligned with the principles in FDA 21 CFR Part 11 for electronic records and signatures, and with data integrity expectations such as ALCOA+. In European contexts, this is often discussed alongside EU GMP Annex 11 for computerized systems.

4) Verification and conformity-assessment methods

GAMP 5 promotes a risk-based verification strategy. In practical terms, the engineer should choose the right evidence method for each requirement based on criticality, complexity, and supplier confidence.

  • Document review: URS, FDS, HDS, network architecture, cybersecurity controls, and supplier manuals
  • Inspection: Panel build quality, labeling, cable management, segregation, grounding, and device IDs
  • Functional testing: I/O checkout, interlocks, alarms, batch sequence behavior, recipe controls, and failover
  • Installation Qualification (IQ): Confirms the system is installed as specified
  • Operational Qualification (OQ): Confirms the system operates within defined ranges and failure modes
  • Performance Qualification (PQ): Confirms the system performs in the actual process context
  • Supplier evidence leverage: Certificates, FAT reports, design history, and validated software release notes

A useful engineering rule is to tie test depth to risk. If a function directly affects batch release data, its verification should be stronger than a convenience HMI feature. A simple risk weighting can be expressed as:

$$R = S \times P \times D$$

where $S$ is severity, $P$ is probability of occurrence, and $D$ is detectability. Higher-risk items require stronger controls, more rigorous testing, and tighter change management.

5) Common pitfalls during certification or inspection

Many GAMP failures are not technical failures; they are documentation and lifecycle failures.

  • Weak URS: Vague statements like “system shall be user friendly” are not testable.
  • Over-customization: Excessive scripting or bespoke PLC logic increases validation burden and maintenance risk.
  • Poor traceability: Requirements not linked to test cases, or tests not linked back to requirements.
  • Uncontrolled vendor changes: Firmware, OS patches, and software updates introduced without impact assessment.
  • Ignoring infrastructure: Network switches, time sync, virtualization, backups, and domain services are often under-validated.
  • Inadequate access control: Shared accounts, weak password policy, or missing audit trail review.
  • Mismatch between design and reality: As-built panels or software differ from approved documents.

Another frequent issue is assuming FAT replaces site qualification. FAT is useful, but it does not prove the system is correctly installed, integrated, or operating in the real process environment.

6) Relationship to adjacent standards

GAMP 5 sits in a broader compliance ecosystem.

  • EU GMP Annex 11: The closest regulatory companion for computerized systems in EU-regulated pharma.
  • 21 CFR Part 11: The U.S. framework for electronic records and signatures.
  • IEC 61511: Relevant where safety instrumented functions are involved; not a validation standard, but often adjacent in process plants.
  • IEC 61131-3: PLC programming languages; useful for code structure and maintainability.
  • IEC 60204-1 / EN 60204-1: Electrical equipment of machines; important for panels, controls, and wiring.
  • IEC 62443: Industrial cybersecurity; increasingly essential for networked SCADA and IIoT systems.
  • ISA-88 / ISA-95: Batch and enterprise integration models that help define software boundaries and data flows.
  • NFPA 79 and NFPA 70: Common in North American machine and electrical installations.

For European projects, it is common to combine GAMP 5 with EN/IEC conformity evidence for machinery and electrical safety, while keeping validation evidence focused on GxP impact. This separation prevents confusion between “safe to operate” and “fit for intended regulated use.”

7) How GAMP 5 shapes design decisions in automation, panels, SCADA, and contracting

GAMP 5 strongly favors simplicity, standardization, and traceability. That changes engineering choices from the earliest design phase.

Automation and PLC design

  • Prefer standard function blocks and proven libraries
  • Minimize custom code unless it is clearly justified by the URS
  • Use clear naming conventions for tags, alarms, and recipes
  • Design for diagnosability: faults should be visible, attributable, and reviewable

Panel design

  • Use durable device labeling and consistent terminal identification
  • Separate critical control wiring from noisy power circuits
  • Provide maintainable layouts that support inspection and requalification
  • Document as-built changes immediately; validation depends on configuration control

SCADA and data architecture

  • Define data ownership for each tag, alarm, and report
  • Implement secure time synchronization for audit trails
  • Control user roles and privileges tightly
  • Validate interfaces to historians, MES, and ERP with particular attention to data mapping and exception handling

Contracting and procurement

  • Write validation deliverables into the purchase specification
  • Require supplier documentation, software version control, and test evidence
  • Clarify who owns FAT, SAT, IQ, OQ, and PQ responsibilities
  • Include change notification obligations for firmware, OS, and application updates

In short, GAMP 5 rewards design choices that reduce ambiguity. Systems that are modular, well documented, and built mostly from standard components are easier to validate, easier to maintain, and easier to inspect.

8) Practical takeaway

Think of GAMP 5 as a disciplined way to prove that a computerized system is suitable for its regulated purpose. It does not ask engineers to validate everything equally; it asks them to validate intelligently, based on risk and intended use. For automation and SCADA teams, the most important habits are clear requirements, disciplined configuration, complete traceability, controlled supplier reliance, and strong change management. If those are in place, certification becomes a structured evidence exercise rather than a painful retrospective documentation scramble.

Services that must comply

Industries where this applies

Frequently asked questions

What is GAMP 5 and how does it differ from a certification or a prescriptive standard in pharma automation projects?

GAMP 5 is a risk-based validation guidance framework published by ISPE for regulated life sciences systems; it is not a certification scheme and it does not prescribe a single technical design. In practice, it helps teams define validation effort based on patient safety, product quality, and data integrity, while technical implementation still follows applicable standards such as IEC 62443 for cybersecurity, IEC 60204-1 for machinery electrical safety, and EN 61010 where relevant.

How is GAMP 5 applied to PLC, SCADA, and batch control systems in a pharma facility?

For PLC, SCADA, and batch systems, GAMP 5 is typically applied by classifying software and configuration elements by complexity and then scaling validation activities to the intended use and risk. Engineers usually combine GAMP 5 with ISA-88 for batch control structures, ISA-95 for enterprise integration, and IEC 61131-3 for PLC software structure to ensure the system design is both testable and maintainable.

What documents are typically expected under a GAMP 5 validation lifecycle for an automation project?

A typical GAMP 5 lifecycle includes user requirements, functional specifications, design specifications, risk assessments, test protocols, traceability, and final validation summary reports. For European projects, these documents are often aligned with Annex 11 expectations for computerized systems, and they should also support electrical and control design records such as panel schematics, I/O lists, and loop diagrams governed by IEC/EN practices.

How should industrial control panels be validated under GAMP 5 on a pharma project?

Control panels are usually validated through a combination of design qualification, factory acceptance testing, and site acceptance testing, with attention to wiring integrity, segregation, labeling, environmental suitability, and software/firmware version control. Panel construction and safety expectations are commonly checked against IEC 61439 for low-voltage assemblies, IEC 60204-1 for machine electrical equipment, and NFPA 79 when North American requirements also apply.

What is the role of risk assessment in GAMP 5 for SCADA and historian systems?

Risk assessment determines which functions, data paths, alarms, audit trails, and interfaces require the most rigorous verification because GAMP 5 is fundamentally risk-based. For SCADA and historian systems, teams often assess data integrity, time synchronization, access control, and event recording, using principles consistent with ISA-18.2 for alarm management and IEC 62443 for system security.

How do European compliance requirements affect GAMP 5 implementation on global pharma projects?

European projects typically require GAMP 5 to be integrated with GMP expectations, especially EU GMP Annex 11 for computerized systems and data integrity controls. In multi-site global projects, engineers often also align hardware and panel design to EN and IEC standards, while documenting qualification evidence so it can be reused across sites without losing local compliance traceability.

What is the difference between Factory Acceptance Testing and Site Acceptance Testing in a GAMP 5 context?

Factory Acceptance Testing verifies the configured system against approved specifications before shipment, while Site Acceptance Testing confirms installation, wiring, network connectivity, utilities, and site-specific functions after delivery. Under GAMP 5, both stages should be traceable to risk-based requirements, and for automation projects they often include checks against PLC logic, SCADA alarms, interlocks, and compliance with applicable IEC and EN installation rules.

How can EPC contractors reduce validation rework when delivering GAMP 5-compliant automation packages?

The best approach is to build validation into the design phase by defining requirements early, standardizing software libraries, controlling versions, and maintaining end-to-end traceability from URS to test evidence. EPC teams also reduce rework by aligning electrical, automation, and cybersecurity design with IEC 61511, IEC 62443, and relevant EN standards before procurement and panel fabrication begin.

Related knowledge